The Impact of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with Clostridium difficile infection

Medical Hypotheses

Volumn 76, Issue 6, 2011, Pages 813-815

  Patel, Shilpa M ^a   Stashefsky, Evan ^b   Maroun, Marie Claire ^b   Johnson, Leonard B ^b,c  

^a Oak Forest Hospital   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADJUVANT THERAPY; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED;

CLOSTRIDIUM DIFFICILE;

EID: 79955718037     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.02.025     Document Type: Article

References (16)

1. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006, 145:758-764.
2. McDonald L.C., Killgore G.E., Thompson A., et al. An Epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
3. Loo V.G., Poirier L., Miller M.A., et al. A Predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
4. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Québec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
5. Warny M., Pépin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
6. Pepin Jacques Improving the Treatment of Clostridium difficile -associated disease: where should we start?. Clin Infect Dis 2006, 43:553-555.
7. Aslam S., Hamill R.J., Musher D.M. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005, 5:549-557.
8. Gullestad L., Aukrust P., Ueland T., et al. Effect of high - versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999, 34:2068-2071.
9. Gage J.R., Fonarow G., Hamilton M., et al. Beta blocker and angiotensin converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure. Neuroimmunomodulation 2004, 11:173-180.
10. Mortensen E.M., Restrepo M.I., Anzueto A., et al. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med 2005, 5:12.
11. Riaz A.A., Wang Y., Scramm R., et al. Role of angiotensin II in ischemia /reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 2004, 18:881-883.
12. Alcantara C.S., Jin X.-H., Brito G.A.C., et al. Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model. J Infect Dis 2005, 191:2090-2096.
13. McGuire T., Dobesh P., Klepser D., Rupp M., Olsen K. Clinically important interaction between statin drugs and Clostridium difficile toxin?. Med Hypoth 2009, 73:1045-1047.
14. Dendukuri N., Costa V., McGregor M., Brophy J.M. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005, 173:167-170.
15. McPherson S., Rees C.J., Ellis R., Soo S., Panter S.J. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 2006, 49:640-645.
16. Musher D.M., Aslam S., Logan N., et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005, 40:1586-1590.